Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06536283 · ClinicalTrials.gov registry record
Opiophobia in Postsurgical Adults With Cancer
A clinical trial of Opiophobia, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06536283 is a study of Opiophobia that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06536283, a study of Opiophobia, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn how people who underwent surgery feel about their prescribed opioid medication after they leave the hospital.
Conditions Studied
Interventions
- OTHER 13-item Barriers Questionnaire (BQ-13)
- OTHER Four-item Medication Adherence Questionnaire
- OTHER 14-item Hospital Anxiety and Depression Scale (HADS)
Study Locations (1)
Texas
- The Univerisity of Texas M. D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-09-16 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06536283
The ClinicalTrials.gov registry entry for NCT06536283 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opiophobia appearing as the primary indexed condition, and to 3 interventions - of which 13-item Barriers Questionnaire (BQ-13) is the first listed.
NCT06536283 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06536283 about?
NCT06536283 is a clinical study titled "Opiophobia in Postsurgical Adults With Cancer". To learn how people who underwent surgery feel about their prescribed opioid medication after they leave the hospital.
What is the current status of trial NCT06536283?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2024-09-16. Estimated completion is 2026-12-31.
What conditions does trial NCT06536283 study?
This clinical trial studies the following conditions: Opiophobia.
What interventions are being tested in trial NCT06536283?
The interventions under investigation include: 13-item Barriers Questionnaire (BQ-13) (OTHER), Four-item Medication Adherence Questionnaire (OTHER), 14-item Hospital Anxiety and Depression Scale (HADS) (OTHER).
Who is sponsoring clinical trial NCT06536283?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06536283 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.